Holen Sie sich die Stockscreener-App
12.00
1.01%
0.12
Handel nachbörslich:
11.96
-0.04
-0.33%
Schlusskurs vom Vortag:
$11.88
Offen:
$11.98
24-Stunden-Volumen:
1.66M
Relative Volume:
0.75
Marktkapitalisierung:
$851.32M
Einnahmen:
$114.04M
Nettoeinkommen (Verlust:
$-330.15M
KGV:
-2.537
EPS:
-4.73
Netto-Cashflow:
$-274.85M
1W Leistung:
-2.91%
1M Leistung:
+38.89%
6M Leistung:
+115.05%
1J Leistung:
-29.41%
1-Tages-Spanne:
$11.25
$12.03
1-Wochen-Bereich:
$11.25
$12.46
52-Wochen-Spanne:
$2.21
$19.71
Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile
Firmenname
Phathom Pharmaceuticals Inc
Sektor
Branche
Telefon
(877) 742-8466
Adresse
100 CAMPUS DRIVE,, FLORHAM PARK, NJ
Vergleichen Sie PHAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHAT
Phathom Pharmaceuticals Inc
|
12.00 | 840.68M | 114.04M | -330.15M | -274.85M | -4.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-05-03 | Eingeleitet | Stifel | Buy |
| 2024-01-05 | Bestätigt | Needham | Buy |
| 2023-08-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-05-11 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-03-13 | Eingeleitet | Craig Hallum | Buy |
| 2022-10-21 | Eingeleitet | Jefferies | Buy |
| 2022-05-06 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-05-12 | Hochstufung | Goldman | Sell → Neutral |
| 2021-02-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-02-02 | Eingeleitet | Guggenheim | Buy |
| 2020-06-26 | Herabstufung | Goldman | Neutral → Sell |
| 2019-11-20 | Eingeleitet | Evercore ISI | Outperform |
| 2019-11-19 | Eingeleitet | Goldman | Neutral |
| 2019-11-19 | Eingeleitet | Jefferies | Buy |
| 2019-11-19 | Eingeleitet | Needham | Buy |
Alle ansehen
Phathom Pharmaceuticals Inc Aktie (PHAT) Neueste Nachrichten
Detecting support and resistance levels for Phathom Pharmaceuticals Inc.Trade Volume Summary & Growth Focused Entry Point Reports - Newser
How to forecast Phathom Pharmaceuticals Inc. trends using time seriesJuly 2025 Momentum & Reliable Intraday Trade Plans - Newser
What the charts say about Phathom Pharmaceuticals Inc. todayJuly 2025 Market Mood & AI Based Buy/Sell Signal Reports - Newser
What’s next for Phathom Pharmaceuticals Inc. stock priceWeekly Investment Recap & AI Based Buy and Sell Signals - Newser
Will Phathom Pharmaceuticals Inc. stock recover after earningsStock Surge & Accurate Intraday Trading Signals - khodrobank.com
Is Phathom Pharmaceuticals Inc. a turnaround storyEarnings Growth Report & Technical Confirmation Alerts - khodrobank.com
Is Phathom Pharmaceuticals Inc. backed by strong institutional buyingJuly 2025 Drop Watch & Risk Managed Investment Signals - khodrobank.com
Chart based analysis of Phathom Pharmaceuticals Inc. trendsStock Surge & Safe Swing Trade Setup Alerts - Newser
Momentum divergence signals in Phathom Pharmaceuticals Inc. chartWeekly Profit Recap & Precise Swing Trade Entry Alerts - Newser
Visual analytics tools that track Phathom Pharmaceuticals Inc. performanceJuly 2025 Drop Watch & Fast Moving Trade Plans - Newser
Institutional scanner results for Phathom Pharmaceuticals Inc.Market Activity Report & Reliable Volume Spike Alerts - Newser
Dividend Watch: Is Phathom Pharmaceuticals Inc. a top pick in the sector2025 Risk Factors & Verified Short-Term Trading Plans - khodrobank.com
Advanced analytics toolkit walkthrough for Phathom Pharmaceuticals Inc.Earnings Summary Report & Daily Momentum Trading Reports - Newser
Is Phathom Pharmaceuticals Inc. still worth holding after the dipWeekly Trade Report & Community Verified Trade Alerts - Newser
How to read the order book for Phathom Pharmaceuticals Inc.Portfolio Risk Summary & Fast Moving Trade Plans - Newser
Combining machine learning predictions for Phathom Pharmaceuticals Inc.Wall Street Watch & Real-Time Chart Breakout Alerts - Newser
Why Phathom Pharmaceuticals Inc. is moving todayPortfolio Update Report & Risk Adjusted Swing Trade Ideas - Newser
Institution Moves: Will Phathom Pharmaceuticals Inc. benefit from rate cuts2025 Valuation Update & Safe Capital Growth Plans - khodrobank.com
Using data filters to optimize entry into Phathom Pharmaceuticals Inc.Volume Spike & Pattern Based Trade Signal System - Newser
Signal strength of Phathom Pharmaceuticals Inc. stock in tech scannersMarket Activity Report & Real-Time Stock Price Movement Reports - Newser
Is Phathom Pharmaceuticals Inc. a top pick in the sectorWeekly Earnings Recap & Growth Oriented Trading Recommendations - khodrobank.com
How moving averages guide Phathom Pharmaceuticals Inc. tradingEarnings Trend Report & Verified Technical Trade Signals - Newser
Published on: 2025-08-31 22:05:23 - Newser
Backtesting results for Phathom Pharmaceuticals Inc. trading strategiesPortfolio Value Report & Accurate Trade Setup Notifications - Newser
Will a bounce in Phathom Pharmaceuticals Inc. offer an exitJuly 2025 Fed Impact & Verified Swing Trading Watchlist - Newser
Can a trend reversal in Phathom Pharmaceuticals Inc. lead to recoveryEarnings Growth Summary & Stepwise Swing Trade Plans - Newser
Phathom Pharmaceuticals Inc. stock retracement – recovery analysis2025 Retail Activity & Real-Time Price Movement Reports - Newser
Is Phathom Pharmaceuticals Inc. the Top Chart Pick This Week getLinesFromResByArray error: size == 0 - thegnnews.com
Published on: 2025-08-31 04:29:11 - Newser
What makes Phathom Pharmaceuticals Inc. stock price move sharplyWeekly Trend Summary & Risk Managed Investment Strategies - Newser
Published on: 2025-08-31 02:28:01 - Newser
How hedge fund analytics apply to Phathom Pharmaceuticals Inc. stockJuly 2025 Drop Watch & Growth Focused Stock Reports - Newser
Can you recover from losses in Phathom Pharmaceuticals Inc.Trade Risk Summary & Technical Pattern Based Signals - Newser
Historical volatility pattern of Phathom Pharmaceuticals Inc. visualizedPortfolio Return Summary & Precise Entry and Exit Recommendations - Newser
Analysts Apply Wyckoff Model to Phathom Pharmaceuticals Inc. Stock getLinesFromResByArray error: size == 0 - 더경남뉴스
Finanzdaten der Phathom Pharmaceuticals Inc-Aktie (PHAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Phathom Pharmaceuticals Inc-Aktie (PHAT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Topper James N | Director |
May 21 '25 |
Buy |
3.86 |
3,780 |
14,609 |
59,403 |
| Topper James N | Director |
May 14 '25 |
Buy |
3.32 |
6,300 |
20,919 |
55,623 |
| Topper James N | Director |
May 13 '25 |
Buy |
3.16 |
1,120 |
3,543 |
49,323 |
| Topper James N | Director |
May 09 '25 |
Buy |
3.22 |
35,602 |
114,616 |
35,602 |
| Topper James N | Director |
May 12 '25 |
Buy |
3.04 |
12,601 |
38,301 |
48,203 |
| Parikh Asit | Director |
May 06 '25 |
Buy |
2.60 |
5,000 |
13,000 |
90,500 |
| Parikh Asit | Director |
May 07 '25 |
Buy |
2.40 |
5,000 |
11,984 |
95,500 |
| Henderson Molly | CFO and CBO |
Apr 07 '25 |
Sale |
4.55 |
3,678 |
16,740 |
89,868 |
| Parikh Asit | Director |
Sep 10 '24 |
Option Exercise |
11.72 |
7,500 |
87,900 |
93,000 |
| Parikh Asit | Director |
Mar 13 '25 |
Buy |
4.42 |
10,000 |
44,200 |
85,500 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):